Sanj Kumar, CEO of ELRIG UK said: “ELRIG is dedicated to delivering great scientific content with diversity and inclusivity built in, and the calibre of talks at this year’s event are testament to that. The keynote speakers are such influential and highly respected scientists in their respective fields. We are delighted to have them lead the scientific programme at Drug Discovery 2023 and support us in driving collaboration across the scientific community as we continue to grow our diverse network.”
Prof Janet Hemingway, founding director of iiCON said: “It’s an honour to be presenting at this year’s Drug Discovery event in Liverpool. I look forward to connecting with thought leaders, sharing insights and gaining new perspectives on key areas of importance in the field and future directions for novel therapeutics.”
Dr Dave Powell, CSO of LifeArc said: “I’m passionate about discovery innovation but also about how we can train and prepare the next generation of drug discovery scientists. So, I’m proud to be presenting at ELRIG’s flagship event this year where new ideas and technology are always to the fore, but importantly ELRIG Drug Discovery is a highly approachable conference for our younger colleagues as well.”
For a full listing of speakers and sessions, to register or book an exhibition stand, please visit:
www.elrig.org/portfolio/drug-discovery-2023/ About ELRIG UK The European Laboratory Research & Innovation Group (ELRIG) is a leading European not-for-profit organisation that exists to provide outstanding scientific content to the life science community. Our values are to always ensure the highest quality of content and that content will be made readily accessible to all, and that we will always be an inclusive organisation, serving a diverse scientific network. In addition, ELRIG will always be a volunteer-led organisation, run by and for the life sciences community. Visit:
www.elrig.org.